In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Otsuka Holdings Co., Ltd.

http://www.otsuka.com/en/

Latest From Otsuka Holdings Co., Ltd.

Happify Health Collaborates With Biogen To Support People Living With Multiple Sclerosis

Biogen and Happy Health announced a pilot partnership to evaluate Happify Health’s Kopa app to support people living with multiple sclerosis. This follows a licensing deal with digital therapeutics developer MedRhythms to support MS patients with gait deficit.

Digital Health Deals

SIFI’s Parasitic Eye Infection Drug & Biosimilar Aflibercept Among Raft Of EU Filings

Polyhexanide, from SIFI, could become the first approved treatment for acanthamoeba keratitis, while aflibercept could become the first biosimilar version of Eylea in the EU.

Europe Drug Review

Hot Flash! Menopause May Not Be Sexy, But Investors Are Warming To Digital Health Solutions

Menopause market is a multi-billion opportunity gaining traction with digital health companies offering solutions to help women manage their symptoms and provide treatment and support. Medtech Insight spoke with three female founders and entrepreneurs, as well as a partner at Lux Capital and clinical lead of ORCHA, about this market. 

Business Strategies Innovation

Hot Flash! Menopause May Not Be Sexy, But Investors Are Warming To Digital Health Solutions

The menopause market is a multi-billion opportunity that is gaining traction with digital health companies offering innovative solutions to help women manage their symptoms and provide treatment and support. Medtech Insight spoke with three female founders and entrepreneurs, as well as a partner at Lux Capital and the clinical lead of ORCHA, about this niche market. 

Digital Health Artificial Intelligence
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Alamo Pharmaceuticals, LLC
    • Astex Pharmaceuticals, Inc.
    • Avanir Pharmaceuticals, Inc.
    • Daiya Foods Inc.
    • Diatranz Otsuka Limited
    • JIMRO Co., Ltd.
    • Korea Otsuka Pharmaceutical Co., Ltd.
    • Mitsui & Co., Ltd
    • Montigen Pharmaceuticals
    • Neurovance, Inc.
    • Otsuka Australia Pharmaceutical Pty Ltd
    • Otsuka Pharmaceutical Factory, Inc.
    • Otsuka Medical Devices Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd
    • Otsuka Pharmaceutical India Private Limited
    • ReCor Medical, Inc.
    • Singapore Otsuka Pharmaceutical Co., Ltd.
    • SuperGen, Inc.
    • Taiwan Otsuka Pharmaceutical Co., Ltd.
    • Taiho Pharmaceutical Co., Ltd.
    • Taiho Pharma Canada, Inc.
    • Visterra Inc.
UsernamePublicRestriction

Register